Editorial Standards & Feedback - Sharecafe
Updated: 1st December 2024 Sequoia Financial Media Pty Ltd (trading as Sharecafe & Finance News Network) has high standards for the quality of its content, and the guiding principles that …
Funding win for Iluka, but shares tumble - Sharecafe
Sequoia Financial Media provides news, information analysis and commentary which is general in nature and not financial or investment advice. Viewers should obtain independent advice …
Latest News - Sharecafe
Sequoia Financial Media provides news, information analysis and commentary which is general in nature and not financial or investment advice. Viewers should obtain independent advice …
Semiconductor Australia 2024 highlights - Sharecafe
The inaugural Semiconductor Australia conference was held on Thursday 24 October at Deloitte, Quay Quarter Tower, Sydney. Stefanie Winwood: Semiconductor Australia 2024 brought …
Now Serving - Sharecafe
market monitor latest news Mortgage Rates Dip Slightly, But Affordability Remains a ConcernPosted onJanuary 24, 2025Trump Slams Fed, OPEC in WEF Address; Markets …
Subscribe Now - Sharecafe
Stay informed and up-to-date, serving up the very best local & international fresh finance news, market movers and expertise. brekkie wrap front of house, daily the latest from global markets …
sip and learn - Sharecafe
Nov 29, 2024 · Dr David Stamler - CEO - Alterity Therapeutics Limited (ASX:ATH) is developing first-in-class therapies to treat neurodegenerative disease. The company's lead drug …
Zipping past expectations - Sharecafe
Zip Co Limited (ASX:ZIP), a digital financial services company that offers point-of-sale credit and digital payment services, has posted robust results for the quarter ending 30 September 2024, …
China’s “big” stimulus – will it work? And what does it mean for ...
Oct 16, 2024 · Sequoia Financial Media provides news, information analysis and commentary which is general in nature and not financial or investment advice. Viewers should obtain …
Reflecting on progress and partnerships at Immutep
Nov 26, 2024 · Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He …